Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles J David

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Nature|January 16, 2020
Publisher Correction: TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1Jie Su, Sophie M Morgani, Charles J David, et al.
Nature Cancer|November 6, 2025
Spatiotemporal control of SMARCA5 by a MAPK-RUNX1 axis distinguishes mutant KRAS-driven pancreatic malignancy from tissue regenerationJing Han, Xiaoman Lu, Mengmeng Guo, et al.
Cell Reports|March 9, 2022
Tumor-derived Jagged1 promotes cancer progression through immune evasionJingjing Meng, Yi-Zhou Jiang, Shen Zhao, et al.
Nature Cancer|February 5, 2022
Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancerYong Li, Yi He, Junya Peng, et al.
Gastroenterology|May 10, 2024
Resolution of Acinar Dedifferentiation Regulates Tissue Remodeling in Pancreatic Injury and Cancer InitiationJonathan Baldan, Juan Camacho-Roda, Marta Ballester, et al.
Cancer Cell|May 1, 2026
A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinomaMeilian Zhuo, Yong Li, Yifeng Zhang, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Nature|January 16, 2020
Publisher Correction: TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1Jie Su, Sophie M Morgani, Charles J David, et al.
Nature Cancer|November 6, 2025
Spatiotemporal control of SMARCA5 by a MAPK-RUNX1 axis distinguishes mutant KRAS-driven pancreatic malignancy from tissue regenerationJing Han, Xiaoman Lu, Mengmeng Guo, et al.
Cell Reports|March 9, 2022
Tumor-derived Jagged1 promotes cancer progression through immune evasionJingjing Meng, Yi-Zhou Jiang, Shen Zhao, et al.
Nature Cancer|February 5, 2022
Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancerYong Li, Yi He, Junya Peng, et al.
Gastroenterology|May 10, 2024
Resolution of Acinar Dedifferentiation Regulates Tissue Remodeling in Pancreatic Injury and Cancer InitiationJonathan Baldan, Juan Camacho-Roda, Marta Ballester, et al.
Cancer Cell|May 1, 2026
A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinomaMeilian Zhuo, Yong Li, Yifeng Zhang, et al.
Pageof 3